MA22880A1 - PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS. - Google Patents

PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS.

Info

Publication number
MA22880A1
MA22880A1 MA23173A MA23173A MA22880A1 MA 22880 A1 MA22880 A1 MA 22880A1 MA 23173 A MA23173 A MA 23173A MA 23173 A MA23173 A MA 23173A MA 22880 A1 MA22880 A1 MA 22880A1
Authority
MA
Morocco
Prior art keywords
preparation
pharmaceutical products
pharmaceutical
products
Prior art date
Application number
MA23173A
Other languages
French (fr)
Inventor
Henry Brown Thomas
Joseph King Ronald
Gwyn Cooper David
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929208871A external-priority patent/GB9208871D0/en
Priority claimed from GB929208859A external-priority patent/GB9208859D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MA22880A1 publication Critical patent/MA22880A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/64—Oxygen atoms
MA23173A 1992-04-24 1993-04-22 PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS. MA22880A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929208871A GB9208871D0 (en) 1992-04-24 1992-04-24 Compounds
GB929208859A GB9208859D0 (en) 1992-04-24 1992-04-24 Compounds

Publications (1)

Publication Number Publication Date
MA22880A1 true MA22880A1 (en) 1993-12-31

Family

ID=26300767

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23173A MA22880A1 (en) 1992-04-24 1993-04-22 PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS.

Country Status (10)

Country Link
EP (1) EP0637303A1 (en)
JP (1) JPH07506104A (en)
KR (1) KR950701330A (en)
CN (1) CN1083055A (en)
AU (1) AU3959893A (en)
CA (1) CA2133984A1 (en)
IL (1) IL105495A0 (en)
MA (1) MA22880A1 (en)
SI (1) SI9300217A (en)
WO (1) WO1993022302A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321811D0 (en) * 1993-10-22 1993-12-15 Smithkline Beecham Plc Pharmaceuticals
CA2185984C (en) * 1995-01-23 2007-12-04 Hirokazu Annoura Medicament for the alleviation or treatment of symptom derived from ischemic disease and compound useful therefor
US5794887A (en) 1995-11-17 1998-08-18 Komerath; Narayanan M. Stagnation point vortex controller
US6251919B1 (en) 1998-02-27 2001-06-26 Warner-Lambert Heterocyclic substituted aniline calcium channel blockers
US6166052A (en) 1998-03-11 2000-12-26 Warner-Lambert Company Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockers
US7417040B2 (en) 2004-03-01 2008-08-26 Bristol-Myers Squibb Company Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US20210309623A1 (en) * 2020-03-11 2021-10-07 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1299247A (en) * 1970-06-22 1972-12-13 Labaz Benzofuran derivatives and process for preparing the same
GB2078217B (en) * 1980-06-14 1984-01-11 Beecham Group Ltd Phenolic ethers their preparation and use
JPS58113140A (en) * 1981-12-14 1983-07-05 シンテツクス（ユ−・エス・エイ）インコ−ポレイテツド Naphthoxyalkyl compound, manufacture and antiinflammatory therefrom
US4851423A (en) * 1986-12-10 1989-07-25 Schering Corporation Pharmaceutically active compounds
DE3706585A1 (en) * 1987-02-25 1988-09-08 Schering Ag ARYL- AND ARYLOXY-SUBSTITUTED TERT.-ALKYLENAMINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR PHARMACEUTICAL USE
CA2020888A1 (en) * 1989-07-27 1991-01-28 Philippe Guerry Substituted aminoalkoxybenzene derivatives
TW199153B (en) * 1990-08-07 1993-02-01 Dtsuka Seiyaku Kk

Also Published As

Publication number Publication date
KR950701330A (en) 1995-03-23
SI9300217A (en) 1993-12-31
AU3959893A (en) 1993-11-29
IL105495A0 (en) 1993-08-18
EP0637303A1 (en) 1995-02-08
JPH07506104A (en) 1995-07-06
CN1083055A (en) 1994-03-02
CA2133984A1 (en) 1993-11-11
WO1993022302A1 (en) 1993-11-11

Similar Documents

Publication Publication Date Title
MA23528A1 (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS
MA22889A1 (en) PROCESS FOR THE PREPARATION OF NEW PRODUCTS
FR2683148B1 (en) PHARMACEUTICAL PRODUCTS FOR CURING TUMOR DISEASES AND PROCESS FOR PREPARING THE SAME.
MA23143A1 (en) PROCESS FOR THE PREPARATION OF VACCINATION COMPOSITIONS.
MA26410A1 (en) PHARMACEUTICAL FORMULATIONS AND PROCESS FOR THEIR PRODUCTION.
ITRM920782A0 (en) PROCEDURE FOR THE PRODUCTION OF SUPER-DUPLEX STAINLESS STEEL PRODUCTS.
KR920701466A (en) Pharmaceutical products for the treatment of immunomodulatory disorders
MA22842A1 (en) PROCESS FOR THE PREPARATION OF VACCINE COMPOSITIONS.
NL193218B (en) Method for the preparation of stainless steel.
MA22819A1 (en) PROCESS FOR THE PREPARATION OF A NEW PHARMACEUTICAL PRODUCT.
MA23518A1 (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS
FR2552664B1 (en) METHOD AND INSTALLATION FOR ENCAPSULATING PRODUCTS, PARTICULARLY FOR PHARMACEUTICAL PRODUCTS
DE2962631D1 (en) Process for the sterilization of pharmaceutical products
MA23118A1 (en) PROCESS FOR THE PREPARATION OF INFLUENZA VACCINE COMPOSITIONS.
FR2629471B1 (en) PROCESS FOR THE PREPARATION OF HALF-LEATHER PRODUCTS
FR2628324B1 (en) ANTIVIRAL AND IMMUNOSTIMULANT PHARMACEUTICAL COMPOSITIONS AND PROCESS FOR PREPARING THE SAME
FR2682088B1 (en) PACKAGING FOR THE EXTEMPORANEOUS PREPARATION OF MEDICINAL PRODUCTS.
AU1122688A (en) Substituted 3,4-dihydro-2h-benzopyrans, processes for their preparation, their use and pharmaceutical products based on these compounds
MA23663A1 (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL FORMULATIONS
PT86874A (en) PROCESS FOR THE PREPARATION OF CHROMONE BY PRODUCTS AND OF PHARMACEUTICAL COMPOUNDS CONTAINING THEM
MA22880A1 (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS.
MA21984A1 (en) PROCESS FOR THE PREPARATION OF QUILINONE DERIVATIVES.
FR2668148B1 (en) NOVEL 5H-BENZODIAZEPINE DERIVATIVE, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND PROCESS FOR PREPARING THE SAME.
FR2655340B1 (en) PROCESS FOR THE PREPARATION OF INTERMEDIATE PRODUCTS FOR THE PREPARATION OF DILTIAZEM.
PT87301A (en) PROCESS FOR THE PREPARATION OF 1,3-DIOXANES BY PRODUCTS AND OF PHARMACEUTICAL COMPOUNDS CONTAINING THEM